University of California San Francisco
Give to UCSF
Precision Medicine Pillar No. 3: Clinical Discovery. Researchers are taking vast amounts of patient data, often collected through first-ever clinical studies, and putting it into tools like MS Bioscreen that have a direct impact on patient care.
Precision Medicine Pillar No. 4: Computational Health Sciences. Computationally intensive approaches are used to analyze and cross-analyze large but discrete collections of data, such as patient health histories and genetic makeup.
Precision Medicine Pillar No. 2: Basic Discovery. The long path to developing potent new treatments often starts with an observation in the lab that then leads to a question about a fundamental life process.
Today, with a host of tools garnered from precision medicine, patients can benefit from precise and effective therapies for some of the world's most daunting illnesses. <em>UCSF Magazine</em> explores the promise of precision medicine.
Precision Medicine Pillar No. 1: Knowledge Network. With an increased ability to harvest information automatically and more powerfully, scientists can find the connections among discoveries that would otherwise go unrecognized.
UCSF faculty members will discuss their cutting-edge approaches to researching and delivering health care on at Dreamforce 2013’s “Unusual Thinkers” track.
The California Institute for Quantitative Biosciences (QB3) will hold a news conference and media tours to launch the institute’s new bioscience incubator, near the UC San Francisco campus at Mission Bay.
Teams of scientists at UCSF are collaborating to build upon existing imaging techniques and find new ways to monitor diseases using creative applications of emerging technologies.
Ray Dolby, PhD, the pioneer of surround-sound and noise reduction technology in modern entertainment and a great friend of UCSF, passed away at his home in San Francisco on Sept. 12, 2013.
The pace at which Nancy Ascher, UCSF’s first female chair of surgery and one of the nation's top doctors, propels through every day is the velocity required for the steep ascent of a remarkable career.
Pharmacologist Lisa Bero, PhD, answers our questions about industry bias in clincial trials.
Shinya Yamanaka's Nobel Prize for stem cell research brought fresh attention to something UCSF long ago sensed and seized: the promise of regeneration medicine for repairing or replacing damaged cells, tissues, and even whole organs.
<p>UCSF is convening some of the world’s foremost thought leaders for a two-day summit to chart the course of precision medicine, an emerging field aimed at revolutionizing medical care.</p>
William Seeley maps the path of frontotemporal dementia through the brain, correlating specific damage with behavioral change. By studying the disease from self to circuits to cells, this visionary neurologist searches for inroads to treatment.
Aside from some challenges, Harry Drake is a happy, active, carefree boy whose life was saved with a bone marrow transplant at UCSF.
Five UCSF scientists – bioengineers Tejal Desai and Shuvo Roy, MD/PhD candidate Mozziyar Etemadi, microbiologist Joe DeRisi, and physician/surgeon Michael Harrison – trace their path toward five inventions that are changing the face of medicine.
<p>A National Academy of Sciences committee co-chaired by UCSF Chancellor Susan Desmond-Hellmann, MD, MPH, recommends the creation of a Google maps-like data network that could transform the future of medical discovery, diagnosis and treatment.</p>